304 related articles for article (PubMed ID: 24018129)
1. Paraneoplastic cerebellar degeneration associated with an onconeural antibody against creatine kinase, brain-type.
Tetsuka S; Tominaga K; Ohta E; Kuroiwa K; Sakashita E; Kasashima K; Hamamoto T; Namekawa M; Morita M; Natsui S; Morita T; Tanaka K; Takiyama Y; Nakano I; Endo H
J Neurol Sci; 2013 Dec; 335(1-2):48-57. PubMed ID: 24018129
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase Cγ antibodies and paraneoplastic cerebellar degeneration.
Höftberger R; Kovacs GG; Sabater L; Nagy P; Racz G; Miquel R; Dalmau J; Graus F
J Neuroimmunol; 2013 Mar; 256(1-2):91-3. PubMed ID: 23273977
[TBL] [Abstract][Full Text] [Related]
3. Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experience.
Ducray F; Demarquay G; Graus F; Decullier E; Antoine JC; Giometto B; Psimaras D; Delattre JY; Carpentier AF; Honnorat J
Eur J Neurol; 2014 May; 21(5):731-5. PubMed ID: 24471811
[TBL] [Abstract][Full Text] [Related]
4. [Paraneoplastic cerebellar degeneration with bladder cancer confirmed the existence of an anti-neural antibody: a case report].
Kawanishi K; Morita M; Nakahara K; Tetsuka S; Kouki T; Tominaga K; Endo H; Yashiro T; Tanaka K; Nakano I
Brain Nerve; 2013 Nov; 65(11):1401-5. PubMed ID: 24200618
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer.
Sabater L; Bataller L; Carpentier AF; Aguirre-Cruz ML; Saiz A; Benyahia B; Dalmau J; Graus F
J Neurol Neurosurg Psychiatry; 2006 Dec; 77(12):1359-62. PubMed ID: 16801349
[TBL] [Abstract][Full Text] [Related]
6. Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: an autopsy case study.
Brieva-Ruíz L; Diaz-Hurtado M; Matias-Guiu X; Márquez-Medina D; Tarragona J; Graus F
Clin Neurol Neurosurg; 2008 Dec; 110(10):1044-6. PubMed ID: 18701208
[TBL] [Abstract][Full Text] [Related]
7. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration.
Albert ML; Austin LM; Darnell RB
Ann Neurol; 2000 Jan; 47(1):9-17. PubMed ID: 10632096
[TBL] [Abstract][Full Text] [Related]
8. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
[TBL] [Abstract][Full Text] [Related]
9. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma.
Xia K; Saltzman JR; Carr-Locke DL
MedGenMed; 2003 Aug; 5(3):18. PubMed ID: 14600654
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma.
Valpione S; Zoccarato M; Parrozzani R; Pigozzo J; Giometto B; Laveder F; Aliberti C; Chiarion-Sileni V
J Neurol Sci; 2013 Dec; 335(1-2):210-2. PubMed ID: 24035275
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic Cerebellar Degeneration: The Importance of Including CDR2L as a Diagnostic Marker.
Herdlevær I; Haugen M; Mazengia K; Totland C; Vedeler C
Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33531379
[TBL] [Abstract][Full Text] [Related]
12. Proteasome antibodies in paraneoplastic cerebellar degeneration.
Storstein A; Knudsen A; Vedeler CA
J Neuroimmunol; 2005 Aug; 165(1-2):172-8. PubMed ID: 15964637
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity.
Panja D; Vedeler CA; Schubert M
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):141-156. PubMed ID: 29679372
[TBL] [Abstract][Full Text] [Related]
14. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
15. Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration.
de Graaff E; Maat P; Hulsenboom E; van den Berg R; van den Bent M; Demmers J; Lugtenburg PJ; Hoogenraad CC; Sillevis Smitt P
Ann Neurol; 2012 Jun; 71(6):815-24. PubMed ID: 22447725
[TBL] [Abstract][Full Text] [Related]
16. Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications.
Yshii L; Bost C; Liblau R
Front Immunol; 2020; 11():991. PubMed ID: 32655545
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
[TBL] [Abstract][Full Text] [Related]
18. ZIC antibodies in paraneoplastic cerebellar degeneration and small cell lung cancer.
Sabater L; Bataller L; Suárez-Calvet M; Saiz A; Dalmau J; Graus F
J Neuroimmunol; 2008 Sep; 201-202():163-5. PubMed ID: 18639938
[TBL] [Abstract][Full Text] [Related]
19. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies.
Storstein A; Krossnes BK; Vedeler CA
Acta Neurol Scand; 2009 Jul; 120(1):64-7. PubMed ID: 19486326
[TBL] [Abstract][Full Text] [Related]
20. [Paraneoplastic cerebellar degeneration].
Sakai K
Brain Nerve; 2010 Apr; 62(4):357-64. PubMed ID: 20420175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
